Position
Chief Scientific Officer
Company
Ankyra Therapeutics
CambridgeBiotechnologyHealthcareSoftwareDescription
Ankyra Therapeutics announced the appointment of Sailaja Battula, PhD, as their new Chief Scientific Officer. Dr. Battula brings extensive experience in immuno-oncology and drug discovery to help shape Ankyra's scientific strategy.
Quick answer
Ankyra Appoints Sailaja Battula as Chief Scientific Officer (December 15, 2025). Ankyra Therapeutics is based in Cambridge, Massachusetts, United States.
- Who is the new Chief Scientific Officer at Ankyra Therapeutics?
- Ankyra Therapeutics named Sailaja Battula Chief Scientific Officer, announced December 15, 2025.
- What did Ankyra Therapeutics announce on December 15, 2025?
- Ankyra Therapeutics announced the appointment of Sailaja Battula, PhD, as their new Chief Scientific Officer. Dr. Battula brings extensive experience in immuno-oncology and drug discovery to help shape Ankyra's scientific strategy.
- What does Ankyra Therapeutics do?
- Ankyra Therapeutics is a biotechnology company that has developed a highly differentiated technology platform that expands the therapeutic window of therapeutic drugs by forming a stable depot after local administration...
- Where is Ankyra Therapeutics based?
- Ankyra Therapeutics is based in Cambridge, Massachusetts, United States.
- Which similar companies made leadership changes around the same time?
- DexCare (December 15, 2025), Research Solutions (December 11, 2025), Enliven Therapeutics (December 11, 2025) and NobleAI (December 5, 2025) also announced leadership changes within 45 days of Ankyra Therapeutics.
Source: Fundz verified event record.
Other recent leadership changes in Healthcare and Biotechnology
Executive moves at companies in the same sectors within 45 days, from Fundz verified event records.
- DexCare Appoints Rakshay Jain as Chief Product Officer (December 15, 2025)
- Dave Kutil Appointed Interim CFO at Research Solutions, Inc. (December 11, 2025)
- Enliven Appoints Rick Fair as Chief Executive Officer (December 11, 2025)
- NobleAI Appoints Alex Wang as Chief Executive Officer (December 5, 2025)
- Katalyze AI Appoints Hannes Bretschneider as Chief AI Officer (December 2, 2025)
- Procyrion Appoints Andrew Davis as Chief Commercial Officer (December 2, 2025)
Who to call at Ankyra Therapeutics, and when
A new leader at Ankyra Therapeutics brings new priorities and often new vendors. The first weeks are when they listen.
- An alert the day Ankyra Therapeutics raises, hires an executive or expands, scored against what you sell
- The decision-makers there, with verified emails
- Who you already know at Ankyra Therapeutics, from your own LinkedIn network
Works inside ChatGPT and Claude. Ask who to call at Ankyra Therapeutics. With Fundz connected, it knows.
AI made execution free. Knowing first is the whole game now.
Fundz sees it the moment Ankyra Therapeutics changes its leadership, hires an exec or expands, usually minutes after it happens, and tells you who to reach.
Related People
Ankyra Therapeutics changed its leadership. Fundz had it the day it was filed, with the decision-maker at the company attached.
145 of these a day, filtered to the companies you pick, with the decision-maker attached.
5 screens from a live account. No signup.